Editorials, Opinion Pieces Address Issues Related To Possible COVID-19 Vaccine

Financial Times: A first glimmer of hope for a Covid vaccine
Editorial Board (11/9).

Financial Times: Does a vaccine against Covid-19 herald the end of the pandemic?
Azra Ghani, professor of infectious disease epidemiology at Imperial College London (11/10).

New York Times: Don’t Get Too Excited About the Coronavirus Vaccine
Aaron E. Carroll, professor of pediatrics at Indiana University School of Medicine, and Nicholas Bagley, law professor at the University of Michigan (11/10).

STAT: A national Covid-19 vaccine confidence project: job No. 1 for President-elect Biden
David Bluestone and John Garrett, both founding partners of ClearPath Strategies, and David Beier, managing director of Bay City Capital (11/8).

Washington Post: The vaccine news is exciting. But keep your mask on
Editorial Board (11/9).

Washington Post: Pfizer’s perfect timing
Daniel W. Drezner, professor of international politics at the Fletcher School of Law and Diplomacy at Tufts University (11/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.